Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 8/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.59 |
| ▸ | MAPT | P10636 | 7/20 | 0.59 |
| ▸ | MAOA | P21397 | 6/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.59 |
| ▸ | DAPK1 | P53355 | 3/20 | 0.59 |
| ▸ | HPGD | P15428 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.59 |
| ▸ | RECQL | P46063 | 3/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.59 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | TTR | P02766 | 2/20 | 0.59 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.59 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31238281 | 0.91 | ELANE (0.56) | ELANEMEN1KMT2AMAPTMAOA | |
| SCHEMBL7100380 | 0.91 | ELANE (0.56) | ELANEMEN1KMT2AMAPTMAOA | |
| SCHEMBL22719979 | 0.87 | ELANE (0.56) | ELANEMEN1KMT2AMAPTMAOA | |
| SCHEMBL899150 | 0.85 | MEN1 (0.68) | ELANEMEN1KMT2AMAPTMAOA | |
| SCHEMBL15315044 | 0.84 | ELANE (0.53) | ELANEMEN1KMT2AMAPTMAOA | |
| SCHEMBL8581315 | 0.81 | MEN1 (0.63) | ELANEMEN1KMT2AMAPTMAOA | |
| Rubiadin SCHEMBL1426928 | 0.81 | BCL2 (0.71) | ELANEMEN1KMT2AMAPTMAOA | |
| Rubiadin SCHEMBL22616292 | 0.81 | BCL2 (0.71) | ELANEMEN1KMT2AMAPTMAOA | |
| Rubiadin SCHEMBL30260037 | 0.81 | BCL2 (0.71) | ELANEMEN1KMT2AMAPTMAOA | |
| Rubiadin SCHEMBL29665059 | 0.81 | BCL2 (0.71) | ELANEMEN1KMT2AMAPTMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0705601-B1 | Anthraquinones containing solutions for parenteral administration | LOMAPHARM (DE) | 2000-01-19 | — | — | EP | claimed |
| EP-0705601-A1 | Anthraquinones containing solutions for parenteral administration | LOMAPHARM Rudolf Lohmann GmbH KG Pharmazeutische Fabrik (DE) | 1996-04-10 | — | — | EP | claimed |
| US-5385842-A | Anthraquinones as inhibitors of sulfide production from sulfate-reducing bacteria | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-01-31 | — | — | US | claimed |
| EP-0525073-B1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | DU PONT (US) | 1994-05-25 | — | — | EP | claimed |
| EP-0525073-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA. | DU PONT (US) | 1993-02-03 | — | — | EP | claimed |
| WO-1991015954-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-31 | — | — | WO | claimed |
| US-20220170904-A1 | SYSTEMS AND METHODS FOR MONITORING BIOLOGICAL TISSUE DEGRADATION | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2022-06-02 | — | — | US | disclosed |
| US-20220109157-A1 | Conducting redox oligomers | SJOEDIN MARTIN (SE) | 2022-04-07 | — | — | US | disclosed |
| CN-113423755-A | Conductive redox oligomers | 马丁·舍丁 | 2021-09-21 | — | — | CN | disclosed |
| CN-109054427-B | Dye, printing ink and electrowetting display device | 深圳市国华光电科技有限公司 | 2021-04-20 | — | — | CN | disclosed |
| WO-2020162824-A1 | CONDUCTING REDOX OLIGOMERS | SJÖDIN MARTIN (SE) | 2020-08-13 | — | — | WO | disclosed |
| US-8105477-B2 | System and method for electrochemical detection of biological compounds | HANDYLAB, INC. (US) | 2012-01-31 | — | — | US | disclosed |
| US-20110039345-A1 | SYSTEM AND METHOD FOR ELECTROCHEMICAL DETECTION OF BIOLOGICAL COMPOUNDS | HANDYLAB, INC. (US) | 2011-02-17 | — | — | US | disclosed |
| US-5385842-A | Anthraquinones as inhibitors of sulfide production from sulfate-reducing bacteria | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-01-31 | — | — | US | disclosed |
| EP-0525073-B1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | DU PONT (US) | 1994-05-25 | — | — | EP | disclosed |
| EP-0533744-A1 | HETEROCYCLIC ANTHRACYCLIONE AND ANTHRACYCLINE ANALOGS | BIOCHEM PHARMA INC. (CA) | 1993-03-31 | — | — | EP | disclosed |
| EP-0525073-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA. | DU PONT (US) | 1993-02-03 | — | — | EP | disclosed |
| WO-1991019725-A2 | HETEROCYCLIC ANTHRACYCLIONE AND ANTHRACYCLINE ANALOGS | BIOCHEM PHARMA INC. (CA) | 1991-12-26 | — | — | WO | disclosed |
| WO-1991015954-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-31 | — | — | WO | disclosed |
| US-4457855-A | HYDROPHOBIC LATEX PARTICLE | THE CLOROX COMPANY (US) | 1984-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220109157-A1 | Conducting redox oligomers | NOX4, CYBB, LPO | ELANE 3112/4885MEN1 4105/4885KMT2A 2086/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.